Efficacy of Different Doses of Daprodustat for Anemic Non-dialysis Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis

(1) Background: Anemia affects about 40% of patients with chronic kidney disease (CKD). Daprodustat improves serum hemoglobin in anemic patients by inhibiting prolyl hydroxylase of hypoxia-inducible factor. We conducted a network meta-analysis to investigate the direct and indirect effects of differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadlalmola, Hammad, Al-Sayaghi, Khaled, Al-Hebshi, Abdulqader, Aljohani, Maher, Albalawi, Mohammed, Kashari, Ohoud, Alem, Alaa, Alrasheedy, Mariam, Balelah, Saud, Almuteri, Faten, Alyamani, Arwa, Alwasaidi, Turki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145143/
https://www.ncbi.nlm.nih.gov/pubmed/35628849
http://dx.doi.org/10.3390/jcm11102722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145143/
https://www.ncbi.nlm.nih.gov/pubmed/35628849
http://dx.doi.org/10.3390/jcm11102722

Ejemplares similares